Funding This work was funded by the Yunnan University Undergraduate Innovation Fund, S202410673138, Yunnan University Medical Research Foundation Department of Radiology, YDYXJJ20250024, Yunnan University Graduate Research Innovation Fund, KC-252512222
KhreissTJozsefLHossainSChanJSDPotempaLAFilepJG
However, on July 23-24, 2026, the FDAs Pharmacy Compounding Advisory Committee (PCAC) voted on inclusion of two of GLOWs peptide compounds for the 503A Bulks List: BPC-157 : 8-6 voted in favor of inclusion, with one abstention TB-500 : 8-6 voted in favor of inclusion, with one abstention Note: TB-500 is a fragment of the full-length thymosin beta-4 (43 amino acids)
For extended protocols or higher doses, a 100 mg vial is more cost-effective
Skipping doses or doubling up disrupts momentum and can lessen the benefits
Angiogenesis (new blood vessel formation) improves tissue oxygenation at the wound site